Disclosures for "Compassionate Use of Kv7.2/7.3 Potassium Channel Activator Opakalim (BHV-7000) in a Child with KCNQ2 Developmental and Epileptic Encephalopathy"
-
Dr. Olson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Takeda pharmaceuticals. The institution of Dr. Olson has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Ovid Therapeutics. The institution of Dr. Olson has received research support from NINDS. The institution of Dr. Olson has received research support from International Foundation for CDKL5 Research. The institution of Dr. Olson has received research support from Marinus Pharmaceuticals. The institution of Dr. Olson has received research support from Ovid Therapeutics.
-
Mrs. Maguire-Lobos has nothing to disclose.
-
Ms. Mansour has nothing to disclose.
-
Mrs. Correa has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acadia Pharmaceuticals. Mrs. Correa has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Acadia Pharmaceuticals.
-
Dr. Lerner has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Dr. Lerner has stock in Biohaven Pharmaceuticals.
-
Dr. Bozik has received personal compensation for serving as an employee of Biohaven . Dr. Bozik has stock in Biohaven.
-
Dr. Dworetzky has received personal compensation for serving as an employee of Biohaven. Dr. Dworetzky has stock in Biohaven. Dr. Dworetzky has received intellectual property interests from a discovery or technology relating to health care.
-
Ms. Sevinsky has received personal compensation for serving as an employee of Biohaven Pharmaceuticals. Ms. Sevinsky has stock in Biohaven Pharmaceuticals.
-
Mrs. Sweeney has nothing to disclose.
-
Dr. Potashman has received personal compensation for serving as an employee of Biohaven Pharmaceuticals.
-
Prof. Paul has nothing to disclose.
-
Racheal Kendrick has received personal compensation for serving as an employee of Certara. Racheal Kendrick has stock in Certara.
-
Dr. Donatelli has nothing to disclose.
-
Dr. Patel has received research support from NIH/NINDS.
-
Dr. Wiltrout has received personal compensation in the range of $0-$499 for serving as a Consultant for Trinity Life Sciences/CAMP4. Dr. Wiltrout has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Stoke Therapeutics. The institution of Dr. Wiltrout has received research support from NIH. The institution of Dr. Wiltrout has received research support from SynGAP Research Fund.
-
Dr. Achkar has nothing to disclose.
-
An immediate family member of Dr. Poduri has received personal compensation for serving as an employee of Beam Therapeutics. An immediate family member of Dr. Poduri has stock in Beam Therapeutics. The institution of Dr. Poduri has received research support from NIH.